Personalized
Medicine
The cancer moonshot of Biontech — 1.5 billion euros investment in 2022
This is a republication of the article below, with the title above. What BioNTech did next: the plan
Read More »
14 de junho de 2022
Personalised prescribing: using pharmacogenomics — Chapter #1 Introduction – “The case for a Pharmacogenomic Approach”
A pharmacogenomic approach, where genetic variation informs choice of drug and dose, can facilitate greater precision in prescribing
Read More »
9 de maio de 2022
The pandemic has forced to redirect clinical trials to be more patient-centric than before
This is a republication of the paper “The next generation of evidence-based medicine — Deep Medicine, AI enabled”, with the
Read More »
17 de março de 2022
Biomarker development has facilitated progress in clinical trial design, with unprecedented advances in genomics and immunology
This is a republication of the paper “The next generation of evidence-based medicine — Deep Medicine, AI enabled”, with the
Read More »
17 de fevereiro de 2022
Pandemic has accelerated clinical trials, and exposed it´s issues — it´s time for a clinical trials transformation
This is a republication of the paper “The next generation of evidence-based medicine — Deep Medicine, AI enabled”, with the
Read More »
30 de janeiro de 2022
